Maternal group B Streptococcus recto vaginal colonization increases the odds of stillbirth: evidence from Eastern Ethiopia

[1]  C. Feldman Faculty Opinions recommendation of Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. , 2018, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[2]  K. Doran,et al.  Group B streptococcus exploits vaginal epithelial exfoliation for ascending infection , 2018, The Journal of clinical investigation.

[3]  V. Gopichandran,et al.  Psycho-social impact of stillbirths on women and their families in Tamil Nadu, India – a qualitative study , 2018, BMC Pregnancy and Childbirth.

[4]  A. Worku,et al.  Vertical transmission of group B Streptococcus and associated factors among pregnant women: a cross-sectional study, Eastern Ethiopia , 2018, Infection and Drug Resistance.

[5]  S. Madhi,et al.  Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  S. Madhi,et al.  Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  S. Madhi,et al.  Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates? , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  S. Madhi,et al.  Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  S. Madhi,et al.  Prospects for preventing infant invasive GBS disease through maternal vaccination. , 2017, Vaccine.

[10]  M. Mahande,et al.  Maternal and fetal risk factors for stillbirth in Northern Tanzania: A registry-based retrospective cohort study , 2017, PloS one.

[11]  S. Madhi,et al.  Challenges in reducing group B Streptococcus disease in African settings , 2016, Archives of Disease in Childhood.

[12]  Eyal Oren,et al.  Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.

[13]  S. Schrag,et al.  Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries , 2016, F1000Research.

[14]  Kidanemariam Alem Berhie,et al.  Logistic regression analysis on the determinants of stillbirth in Ethiopia , 2016, Maternal Health, Neonatology and Perinatology.

[15]  J. Wrammert,et al.  Incidence of intrapartum stillbirth and associated risk factors in tertiary care setting of Nepal: a case-control study , 2016, Reproductive Health.

[16]  S. Madhi,et al.  Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. , 2016, The Lancet. Infectious diseases.

[17]  S. Madhi,et al.  Serotype-Specific Cell-Mediated Immunity Associated With Clearance of Homotypic Group B Streptococcus Rectovaginal Colonization in Pregnant Women. , 2016, The Journal of infectious diseases.

[18]  Neil J Sebire,et al.  Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement. , 2016, Archives of pathology & laboratory medicine.

[19]  S. Schrag,et al.  Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya , 2016, Nature Microbiology.

[20]  David Osrin,et al.  Stillbirths: rates, risk factors, and acceleration towards 2030 , 2016, The Lancet.

[21]  Z. Dangor,et al.  Maternal group B Streptococcus‐related stillbirth: a systematic review , 2015, BJOG : an international journal of obstetrics and gynaecology.

[22]  K. Kerber,et al.  Weeping in silence: community experiences of stillbirths in rural eastern Uganda , 2015, Global health action.

[23]  K. Kerber,et al.  Weeping in silence: community experiences of stillbirths in rural eastern Uganda , 2015, Global health action.

[24]  G. Debelew,et al.  Determinants and Causes of Neonatal Mortality in Jimma Zone, Southwest Ethiopia: A Multilevel Analysis of Prospective Follow Up Study , 2014, PloS one.

[25]  Jai K Das,et al.  Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost? , 2014, The Lancet.

[26]  V. Nizet,et al.  Group B Streptococcus β-hemolysin/cytolysin breaches maternal-fetal barriers to cause preterm birth and intrauterine fetal demise in vivo. , 2014, The Journal of infectious diseases.

[27]  H. Kidanto,et al.  Grand multiparity: is it still a risk in pregnancy? , 2013, BMC Pregnancy and Childbirth.

[28]  T. Moussa,et al.  Group B streptococcus colonization of pregnant women: comparative molecular and microbiological diagnosis , 2013, Comparative Clinical Pathology.

[29]  S. Goodman,et al.  Causal inference in public health. , 2013, Annual review of public health.

[30]  K. McGeechan,et al.  Risk factors for antepartum stillbirth and the influence of maternal age in New South Wales Australia: A population based study , 2013, BMC Pregnancy and Childbirth.

[31]  H. D. Liggitt,et al.  Choriodecidual Group B Streptococcal Inoculation Induces Fetal Lung Injury without Intra-Amniotic Infection and Preterm Labor in Macaca nemestrina , 2011, PloS one.

[32]  L. Wright,et al.  Causes of community stillbirths and early neonatal deaths in low-income countries using verbal autopsy: an International, Multicenter Study , 2012, Journal of Perinatology.

[33]  J. Troendle,et al.  Assessment of Intrapartum Antibiotic Prophylaxis for the Prevention of Early-onset Group B Streptococcal Disease , 2011, The Pediatric infectious disease journal.

[34]  Stephanie Schrag,et al.  Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC , 2002 .

[35]  M. Vaneechoutte,et al.  Genotyping of Streptococcus agalactiae (group B streptococci) isolated from vaginal and rectal swabs of women at 35-37 weeks of pregnancy , 2009, BMC infectious diseases.

[36]  D. Hardy,et al.  The effect of intrapartum penicillin on vaginal group B streptococcus colony counts. , 2007, American journal of obstetrics and gynecology.

[37]  V. Clifton,et al.  Alterations in the Maternal Peripheral Microvascular Response in Pregnancies Complicated by Preeclampsia and the Impact of Fetal Sex , 2006, The Journal of the Society for Gynecologic Investigation: JSGI.

[38]  Lilani Kumaranayake,et al.  Constructing socio-economic status indices: how to use principal components analysis. , 2006, Health policy and planning.

[39]  D W Hosmer,et al.  Parameter Estimation and Goodness‐of‐Fit in Log Binomial Regression , 2006, Biometrical journal. Biometrische Zeitschrift.

[40]  Monica Cheesbrough,et al.  District Laboratory Practice in Tropical Countries: Acknowledgements , 2005 .

[41]  Kate C. Arnold,et al.  Use of Prophylactic Antibiotics in Labor and Delivery , 2017 .

[42]  L. Sibley,et al.  A qualitative study of attitudes and values surrounding stillbirth and neonatal mortality among grandmothers, mothers, and unmarried girls in rural Amhara and Oromiya regions, Ethiopia: unheard souls in the backyard. , 2014, Journal of midwifery & women's health.

[43]  L. Myatt,et al.  Effect of preeclampsia on placental function: influence of sexual dimorphism, microRNA's and mitochondria. , 2014, Advances in experimental medicine and biology.

[44]  S. Schrag,et al.  Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[45]  S. Schrag,et al.  Morbidity and Mortality Weekly Report (MMWR) Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC, 2010 Recommendations and Reports , 2010 .